132 related articles for article (PubMed ID: 31360742)
1. Effects of malaria/helminthic coinfections on cervical cancer progression among sub Saharan African women on highly active antiretroviral therapy: A scoping review.
Menon S; Rodolfo R; Akudibillah G; Dusabimana A; Harmon S; Mabeya H
Gynecol Oncol Rep; 2019 Aug; 29():64-69. PubMed ID: 31360742
[TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.
Crepaz N; Hart TA; Marks G
JAMA; 2004 Jul; 292(2):224-36. PubMed ID: 15249572
[TBL] [Abstract][Full Text] [Related]
3. Malaria and helminthic co-infection among HIV-positive pregnant women: prevalence and effects of antiretroviral therapy.
Ivan E; Crowther NJ; Rucogoza AT; Osuwat LO; Munyazesa E; Mutimura E; Njunwa KJ; Zambezi KJ; Grobusch MP
Acta Trop; 2012 Dec; 124(3):179-84. PubMed ID: 22940013
[TBL] [Abstract][Full Text] [Related]
4. Public health approach to prevent cervical cancer in HIV-infected women in Kenya: Issues to consider in the design of prevention programs.
Menon S; Rossi R; Harmon SG; Mabeya H; Callens S
Gynecol Oncol Rep; 2017 Nov; 22():82-88. PubMed ID: 29159260
[TBL] [Abstract][Full Text] [Related]
5. HAART use in women with HIV and influence on cervical intraepithelial neoplasia: a clinical opinion.
Khanna N
J Low Genit Tract Dis; 2002 Apr; 6(2):111-5. PubMed ID: 17051009
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Highly Active Antiretroviral Therapy (HAART) and human papillomavirus type 16 (HPV 16) infection among women in Sub-Saharan Africa and public health implications: A systematic review.
Menon S; Rossi R; Kariisa M; Acharya SD; Zdraveska N; Mahmood S; Callens S; Ndizeye Z
PLoS One; 2019; 14(3):e0213086. PubMed ID: 30856196
[TBL] [Abstract][Full Text] [Related]
7. Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa.
Auvert B; Males S; Puren A; Taljaard D; Caraël M; Williams B
J Acquir Immune Defic Syndr; 2004 May; 36(1):613-21. PubMed ID: 15097305
[TBL] [Abstract][Full Text] [Related]
8. Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation.
Atashili J; Smith JS; Adimora AA; Eron J; Miller WC; Myers E
PLoS One; 2011 Apr; 6(4):e18527. PubMed ID: 21483701
[TBL] [Abstract][Full Text] [Related]
9. HIV-related oral disease epidemiology among women: year 2000 update.
Shiboski CH
Oral Dis; 2002; 8 Suppl 2():44-8. PubMed ID: 12164659
[TBL] [Abstract][Full Text] [Related]
10. Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentary.
Menon S; Rossi R; Kariisa M; Callens S
Virol J; 2018 Aug; 15(1):129. PubMed ID: 30115083
[TBL] [Abstract][Full Text] [Related]
11. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
Omonaiye O; Kusljic S; Nicholson P; Manias E
BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
[TBL] [Abstract][Full Text] [Related]
12. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa.
ter Kuile FO; Parise ME; Verhoeff FH; Udhayakumar V; Newman RD; van Eijk AM; Rogerson SJ; Steketee RW
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):41-54. PubMed ID: 15331818
[TBL] [Abstract][Full Text] [Related]
13. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
Sangani P; Rutherford G; Wilkinson D
Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
[TBL] [Abstract][Full Text] [Related]
14. The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa.
Kaye DK; Kakaire O; Osinde MO; Lule JC; Kakande N
J Infect Dev Ctries; 2013 Jun; 7(6):436-47. PubMed ID: 23771287
[TBL] [Abstract][Full Text] [Related]
15. HPV oral lesions in HIV-infected patients: the impact of long-term HAART.
Anaya-Saavedra G; Flores-Moreno B; García-Carrancá A; Irigoyen-Camacho E; Guido-Jiménez M; Ramírez-Amador V
J Oral Pathol Med; 2013 Jul; 42(6):443-9. PubMed ID: 23278731
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
[TBL] [Abstract][Full Text] [Related]
17. The impact of highly active antiretroviral therapy on obstetric conditions: A review.
Sebitloane HM; Moodley D
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():126-131. PubMed ID: 28013100
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.
Silverberg MJ; Gore ME; French AL; Gandhi M; Glesby MJ; Kovacs A; Wilson TE; Young MA; Gange SJ
Clin Infect Dis; 2004 Sep; 39(5):717-24. PubMed ID: 15356788
[TBL] [Abstract][Full Text] [Related]
19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
20. Women and HIV. Epidemiology and global overview.
Fowler MG; Melnick SL; Mathieson BJ
Obstet Gynecol Clin North Am; 1997 Dec; 24(4):705-29. PubMed ID: 9430163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
